Novo Nordisk (NVO) Seeks Emergency Injunction Against Eli Lilly’s Drug Advertising

Novo Nordisk (NVO) files court motion to immediately stop Eli Lilly's weight-loss drug ads, alleging misleading comparisons with Wegovy and Ozempic.

The post Novo Nordisk (NVO) Seeks Emergency Injunction Against Eli Lilly’s Drug Advertising appeared first on Blockonomi.